✨ Free AI Report
Tonix Pharmaceuticals Holding Corp.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Tonix Pharmaceuticals Holding Corp.
Research Preview

Tonix Pharmaceuticals Holding Corp.: Business Overview, Financials & Competitive Analysis

Tonix Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and prevent human disease. The company received FDA approval and launched Tonmya, the first new fibr...

Analyst-debate audio for Tonix Pharmaceuticals Holding Corp.

AskCyborg analysts argue the bull and bear cases for Tonix Pharmaceuticals Holding Corp. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Tonix Pharmaceuticals Holding Corp. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Early-stage commercial biotech with FDA-approved fibromyalgia treatment and promising pipeline, but elevated risk profile...

Read the full analyst-debate transcript →
Industry Biopharmaceutical - CNS Disorders, Pain Management, Immunology, Infectious Disease, and Rare Disease
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 22, 2026
AI-Verified Research
30+ Page Report

Get the Latest Tonix Pharmaceuticals Holding Corp. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Tonix Pharmaceuticals Holding Corp. Overview

Pro stress-test →

Tonix Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and prevent human disease. The company received FDA approval and launched Tonmya, the first new fibromyalgia drug in over 15 years, and markets Zembrace SymTouch and Tosymra for the treatment of acute migraine with or without aura in adults.

Strategic Profile

Pro stress-test →

The company's portfolio focuses on central nervous system disorders, as well as immunology, infectious disease, and rare disease product candidates. Tonix has made significant strides with a $20 million registered direct offering and updates on its promising drug candidates, including TNX-4800 for Lyme disease prevention and TNX-4900 for chronic pain.

Competitive Landscape

Pro stress-test →

Tonix markets migraine treatments Zembrace SymTouch and Tosymra. The company competes in multiple therapeutic areas including CNS disorders, pain management, immunology, and rare diseases, with differentiation through its newly approved Tonmya fibromyalgia treatment and innovative pipeline programs targeting underserved indications like Lyme disease prevention.

Industry Context

Tonix Pharmaceuticals Holding Corp. operates in Biopharmaceutical - CNS Disorders, Pain Management, Immunology, Infectious Disease, and Rare Disease.

Key facts

Founded: 2011 · Headquarters: Berkeley Heights, NJ, US · Revenue: $10.09M (2024)

What the analysts stress-tested

The top findings that survived the multi-agent debate for Tonix Pharmaceuticals Holding Corp..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Tonix Pharmaceuticals Holding Corp. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Fibromyalgia treatmentsEstablished pain management franchise→Migraine therapeuticsCompeting migraine prevention and acute treatments→CNS disorder therapiesOther CNS-focused biotech companies→

Compare Tonix Pharmaceuticals Holding Corp. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Tonix Pharmaceuticals Holding Corp. operates in Biopharmaceutical - CNS Disorders, Pain Management, Immunology, Infectious Disease, and Rare Disease. See how the rest of the sector scores on the Cyborg framework.

Browse Biopharmaceutical - CNS Disorders, Pain Management, Immunology, Infectious Disease, and Rare Disease research →
NEW · MCP server

Ask your AI assistant about Tonix Pharmaceuticals Holding Corp.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Tonix Pharmaceuticals Holding Corp. and its top competitor on Cyborg Score”
“What did Tonix Pharmaceuticals Holding Corp. do this quarter?”
“Is Tonix Pharmaceuticals Holding Corp. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Tonix Pharmaceuticals Holding Corp. do?+
Tonix Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics to treat and prevent human disease. The company received FDA approval and launched Tonmya, the first new fibr...
What is Tonix Pharmaceuticals Holding Corp.'s Cyborg Score?+
Tonix Pharmaceuticals Holding Corp. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Tonix Pharmaceuticals Holding Corp.'s main competitors?+
Named competitors include Fibromyalgia treatments, Migraine therapeutics, CNS disorder therapies. The full competitive landscape is in the AskCyborg report.
How can I get the full Tonix Pharmaceuticals Holding Corp. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Tonix Pharmaceuticals Holding Corp. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Tonix Pharmaceuticals Holding Corp. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Anthropic9Dubai Electricity and Water Authority (DEWA)9Emaar Development PJSC9Gold Fields Limited9Western Digital Corporation9Advantest Corporation9Fast Retailing Co., Ltd.9JPMorgan Chase & Co.9Siemens AG9Space Exploration Technologies Corp8Arcellx, Inc.8Gentili Mosconi S.p.A.8Neurogene Inc.8Selvaag Bolig ASA8Satellogic Inc.8Klaveness Combination Carriers ASA8Unusual Machines, Inc.8Shoei Co., Ltd.